The Blog
-
Jul 10, 2025VEGFR-2 in Focus: Structure, Signaling, and Its Emerging Role in Disease and Therapy
READ MORE -
Jun 25, 2025Targeting Focal Adhesion Kinase in Cancer: Advances in Inhibitors and PROTAC-Based Degraders
READ MORE -
May 20, 2025Tyrosine Kinases in Cancer: From Molecular Mechanisms to Targeted Therapies
READ MORE -
Apr 24, 2025Targeted Protein Degradation and PROTACs: Transforming the Future of Cancer Therapy
READ MORE -
Mar 04, 2025Laduviglusib: A GSK3β Inhibitor with Potential Across Multiple Diseases
READ MORE -
Feb 17, 2025Zenocutuzumab: A Dual-Targeted Monoclonal Antibody for HER2 and HER3-Driven Cancers
READ MORE -
Dec 17, 2024Targeting β-Adrenergic Receptor Signaling: A Promising Strategy in Cancer Therapy
READ MORE -
Dec 11, 2024The Impact of Bacterial Infections on Cancer: Mechanisms, Implications, and Future Directions in Treatment
READ MORE -
Nov 27, 2024Targeting DNA Damage Checkpoint Kinases: A New Frontier in Precision Cancer Therapy
READ MORE